Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT06306157
Eligibility Criteria:
Inclusion Criteria:
* Between 18 and 65 years old
* Meeting CRPS diagnostic criteria using the Budapest Clinical Diagnostic Criteria
* CRPS patients with severe pain (NRS\>3) that affects their daily life.
* CRPS patients with pain and other symptoms for more than 3 months.
Exclusion Criteria:
* Patients with suspected disc herniation, spinal stenosis, myelopathy, and suspected radiculopathy in detailed examinations and examinations (MRI, CT).
* Systemic or local infection
* Malignancy
* Current or planned pregnancy within the study period.
* Uncontrolled medical and psychiatric condition
* Patients with known liver issues, including but not limited to end-stage liver disease, severe cirrhosis or an acute hepatic state.
* Patients who are currently using opioid drugs
* Patients who are currently using alcohol or considering using alcohol during the study period.
* Allergy to naltrexone or naloxone
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT06306157
Study Brief:
Protocol Section:
NCT06306157